Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to find out how well participants with relapsed or
refractory ALL respond to treatment with an etoposide- and teniposide-based induction
chemotherapy regimen and what the side effects are.
Primary Objectives:
- To estimate the response rate for patients with refractory or relapsed ALL.
- To estimate the survival rate of patients with refractory or relapsed ALL treated with
risk-directed therapy.